News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
763,209 Results
Type
Article (57619)
Company Profile (612)
Press Release (704978)
Multimedia
Podcasts (73)
Webinars (13)
Section
Business (216225)
Career Advice (2808)
Deals (37370)
Drug Delivery (119)
Drug Development (86336)
Employer Resources (182)
FDA (17675)
Job Trends (15998)
News (369076)
Policy (37006)
Tag
Academia (2930)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (92)
Alliances (53389)
ALS (104)
Alzheimer's disease (1483)
Antibody-drug conjugate (ADC) (156)
Approvals (17648)
Artificial intelligence (313)
Autoimmune disease (27)
Automation (17)
Bankruptcy (384)
Best Places to Work (12420)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (425)
Bladder cancer (86)
Brain cancer (30)
Breast cancer (311)
Cancer (2461)
Cardiovascular disease (201)
Career advice (2359)
Career pathing (33)
CAR-T (173)
Cell therapy (481)
Cervical cancer (22)
Clinical research (70023)
Collaboration (923)
Company closure (2)
Compensation (586)
Complete response letters (26)
COVID-19 (2848)
CRISPR (48)
C-suite (270)
Cystic fibrosis (108)
Data (2376)
Decentralized trials (2)
Denatured (21)
Depression (53)
Diabetes (295)
Diagnostics (6823)
Digital health (21)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (139)
Drug pricing (129)
Drug shortages (30)
Duchenne muscular dystrophy (101)
Earnings (90416)
Editorial (45)
Employer branding (21)
Employer resources (156)
Events (120267)
Executive appointments (776)
FDA (19116)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (822)
Gene editing (121)
Generative AI (30)
Gene therapy (353)
GLP-1 (816)
Government (4980)
Grass and pollen (5)
Guidances (158)
Healthcare (20396)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (141)
Indications (30)
Infectious disease (3011)
Inflammatory bowel disease (155)
Inflation Reduction Act (9)
Influenza (58)
Intellectual property (103)
Interviews (498)
IPO (17272)
IRA (47)
Job creations (4051)
Job search strategy (1974)
Kidney cancer (11)
Labor market (43)
Layoffs (535)
Leadership (23)
Legal (9146)
Liver cancer (82)
Lung cancer (347)
Lymphoma (159)
Machine learning (9)
Management (62)
Manufacturing (359)
MASH (81)
Medical device (14349)
Medtech (14354)
Mergers & acquisitions (20674)
Metabolic disorders (777)
Multiple sclerosis (87)
NASH (17)
Neurodegenerative disease (109)
Neuropsychiatric disorders (30)
Neuroscience (2085)
NextGen: Class of 2025 (7334)
Non-profit (4961)
Now hiring (40)
Obesity (411)
Opinion (256)
Ovarian cancer (83)
Pain (102)
Pancreatic cancer (89)
Parkinson's disease (162)
Partnered (22)
Patents (259)
Patient recruitment (119)
Peanut (50)
People (60590)
Pharmaceutical (125)
Pharmacy benefit managers (22)
Phase I (21777)
Phase II (30611)
Phase III (22994)
Pipeline (1404)
Policy (169)
Postmarket research (3003)
Preclinical (9388)
Press Release (71)
Prostate cancer (114)
Psychedelics (34)
Radiopharmaceuticals (267)
Rare diseases (425)
Real estate (6472)
Recruiting (70)
Regulatory (25209)
Reports (49)
Research institute (2600)
Resumes & cover letters (461)
Rett syndrome (6)
RNA editing (5)
RSV (50)
Schizophrenia (80)
Series A (138)
Series B (94)
Service/supplier (25)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (160)
Sponsored (32)
Startups (3929)
State (2)
Stomach cancer (16)
Supply chain (73)
Tariffs (56)
The Weekly (50)
Vaccines (807)
Venture capitalists (44)
Weight loss (281)
Women's health (36)
Worklife (19)
Date
Today (184)
Last 7 days (1006)
Last 30 days (3256)
Last 365 days (34767)
2025 (12674)
2024 (37408)
2023 (41992)
2022 (53372)
2021 (58166)
2020 (57012)
2019 (50210)
2018 (38169)
2017 (35125)
2016 (35090)
2015 (40958)
2014 (34794)
2013 (30035)
2012 (32256)
2011 (32822)
2010 (30816)
Location
Africa (941)
Alabama (60)
Alaska (7)
Arizona (248)
Arkansas (13)
Asia (43296)
Australia (7350)
California (6668)
Canada (2100)
China (574)
Colorado (287)
Connecticut (304)
Delaware (167)
Europe (97035)
Florida (976)
Georgia (227)
Hawaii (1)
Idaho (61)
Illinois (600)
India (28)
Indiana (340)
Iowa (12)
Japan (175)
Kansas (111)
Kentucky (27)
Louisiana (14)
Maine (62)
Maryland (990)
Massachusetts (5087)
Michigan (234)
Minnesota (424)
Mississippi (2)
Missouri (90)
Montana (31)
Nebraska (25)
Nevada (70)
New Hampshire (68)
New Jersey (1863)
New Mexico (31)
New York (1864)
North Carolina (1099)
North Dakota (9)
Northern California (2879)
Ohio (221)
Oklahoma (15)
Oregon (43)
Pennsylvania (1465)
Puerto Rico (13)
Rhode Island (36)
South America (1335)
South Carolina (26)
South Dakota (1)
Southern California (2477)
Tennessee (108)
Texas (998)
United States (25254)
Utah (194)
Virginia (171)
Washington D.C. (71)
Washington State (605)
West Virginia (3)
Wisconsin (70)
763,209 Results for "us oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community
April 16, 2025
·
10 min read
Press Releases
NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform
April 30, 2025
·
4 min read
Press Releases
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
May 8, 2025
·
5 min read
Layoffs
Eisai Will Trim About 7% of US Workforce, Including New Jersey Employees
Eisai’s cuts will affect 121 employees across the Japanese company’s U.S. operations, including 57 people at its American headquarters in Nutley, New Jersey. A company spokesperson said the pharma remains fully committed to the U.S. market.
February 28, 2025
·
1 min read
·
Angela Gabriel
Manufacturing
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans
In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing investments in the U.S., including Eli Lilly, Johnson & Johnson and Novartis. BMS is the latest to make a multibillion-dollar push.
May 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14, 2025
·
9 min read
Press Releases
CereVasc, Inc. Receives FDA Breakthrough Device Designation for the eShunt® System for Use in Pediatric Patients
April 23, 2025
·
4 min read
Press Releases
Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio
April 10, 2025
·
8 min read
Press Releases
Catheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product Line
April 14, 2025
·
2 min read
Manufacturing
Novartis Pledges $23B Boost to US Ops as Trump Intensifies Tariff Threats
Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The new facilities will include a biomedical research hub in California, two radioligand plants, and four manufacturing sites.
April 11, 2025
·
2 min read
·
Tristan Manalac
1 of 76,321
Next
